STOCKS IN ACTION 19 january
Adani Enterprises: The company filed the RHP for its Rs 20,000-crore follow-on public offering, with floor price at Rs 3,112 apiece and cap price at Rs 3,276 per share. The company also announced a discount of Rs 64 per share for retail buyers.
Vedanta: The company will acquire the debt-laden Meenakshi Energy for Rs 1,440 crore.
State Bank of India: The bank raised Rs 9,718 crore through 15-year infrastructure bonds at 7.7% coupon rate.
Aurobindo Pharma: The company’s subsidiary APL Health Care received Form 483 with two observations from U.S. FDA following an inspection of its unit I and III, an orals and derma manufacturing facility in Jadcherla, Telangana.
Coal India: In a coal ministry review, the company was found to have produced 513 million tonnes of coal so far in fiscal 2023, and is expected to surpass the target of 700 million tonnes for the current fiscal. The ministry has pegged the production target for the company during 2023-24 at 780 million tonnes.
Kotak Mahindra Bank: The board in its meeting scheduled on Jan. 21 will consider raising funds via non-convertible debentures during the remaining period of FY 2022-23, and by the way of NCDs, bonds or other debt securities during FY24.
Welspun Enterprises: The board of the company has approved voluntary liquidation of subsidiary Welspun Natural Resources to streamline the structure and reduce administrative overheads of the group.
Mahindra Lifespaces Developers: The company has been selected to redevelop two adjacent residential societies in Santacruz West, Mumbai. The project has a revenue potential of Rs 500 crore.
Wipro: The company opened Wipro-AWS Launch Pad Center in Toronto, Canada
Aurobindo Pharma: US FDA issued a ‘Form 483’ with 2 observations for Unit I & III of APL HealthCare. The observations are procedural in nature
Gulshan Polyols: To Acquire Upto 40% Stake JGN Sugar And Biofuels Pvt Ltd
DCM Shriram: Expansion From 200 KLD To 320 KLD Expansion Of Distillation Capacity At Ajbapur Sugar Unit Commissioned Commissioning Effective From Jan. 16
KDDL: Co Approved The Proposal Of Buyback Of Equity Shares Of The Co At A Price Not Exceeding 1200 Rupees Per Equity Share ("Maximum Buyback Price") And For An Aggregate Amount Not Exceeding 210m Rupees ("Maximum Buyback Size") From The Shareholders Of The Co Through Open Market Route
@daytradertelugu
Adani Enterprises: The company filed the RHP for its Rs 20,000-crore follow-on public offering, with floor price at Rs 3,112 apiece and cap price at Rs 3,276 per share. The company also announced a discount of Rs 64 per share for retail buyers.
Vedanta: The company will acquire the debt-laden Meenakshi Energy for Rs 1,440 crore.
State Bank of India: The bank raised Rs 9,718 crore through 15-year infrastructure bonds at 7.7% coupon rate.
Aurobindo Pharma: The company’s subsidiary APL Health Care received Form 483 with two observations from U.S. FDA following an inspection of its unit I and III, an orals and derma manufacturing facility in Jadcherla, Telangana.
Coal India: In a coal ministry review, the company was found to have produced 513 million tonnes of coal so far in fiscal 2023, and is expected to surpass the target of 700 million tonnes for the current fiscal. The ministry has pegged the production target for the company during 2023-24 at 780 million tonnes.
Kotak Mahindra Bank: The board in its meeting scheduled on Jan. 21 will consider raising funds via non-convertible debentures during the remaining period of FY 2022-23, and by the way of NCDs, bonds or other debt securities during FY24.
Welspun Enterprises: The board of the company has approved voluntary liquidation of subsidiary Welspun Natural Resources to streamline the structure and reduce administrative overheads of the group.
Mahindra Lifespaces Developers: The company has been selected to redevelop two adjacent residential societies in Santacruz West, Mumbai. The project has a revenue potential of Rs 500 crore.
Wipro: The company opened Wipro-AWS Launch Pad Center in Toronto, Canada
Aurobindo Pharma: US FDA issued a ‘Form 483’ with 2 observations for Unit I & III of APL HealthCare. The observations are procedural in nature
Gulshan Polyols: To Acquire Upto 40% Stake JGN Sugar And Biofuels Pvt Ltd
DCM Shriram: Expansion From 200 KLD To 320 KLD Expansion Of Distillation Capacity At Ajbapur Sugar Unit Commissioned Commissioning Effective From Jan. 16
KDDL: Co Approved The Proposal Of Buyback Of Equity Shares Of The Co At A Price Not Exceeding 1200 Rupees Per Equity Share ("Maximum Buyback Price") And For An Aggregate Amount Not Exceeding 210m Rupees ("Maximum Buyback Size") From The Shareholders Of The Co Through Open Market Route
@daytradertelugu